03:58 PM EST - Helix BioPharma Corp. : reported for the third quarter of fiscal 2009, ended April 30, 2009 a wider loss of $4.13 million or $0.08 per share, compared to a loss of $1.14 million or $0.03 per share in the prior-year period. Quarterly revenues were $924,000, down from $1.0 million a year ago. Helix BioPharma Corp.
shares T.HBP are trading down $0.07 at $1.33.
